[1] FREEMAN ML,GUDA NM.Prevention of post-ERCP pancreatitis:a comprehensive review[J].Gastrointest Endosc,2004,59(7):845.
[2]
[3] 刘建强,李达周,张志坚,等.青年病人内镜下乳头球囊扩张术后胰腺炎的危险因素分析[J].中华胰腺病杂志,2015,15(3):154.
[4] 尹延伟,张金泉,孙倩倩,等.ERCP联合EST治疗与病人术后发生急性胰腺炎关系的Meta分析[J].循证医学,2014,14(1):57.
[5] KOKSAL AR,BOGA S,ALKIM H,et al.Insulin resistance as a novel risk factor for post-ERCP pancreatitis:a pilot study[J].Dig Dis Sci,2016,61(8):2397.
[6] 柴宁莉,令狐恩强,万军,等.胆管超选技术降低ERCP术后胰腺炎发生率的对照研究[J].中华肝胆外科杂志,2010,16(5):336.
[7]
[8] MASCI E,MANGIAVILLANO B,LUIGIANO C,et al.Comparison between loop-tip guide wire-assisted and conventional endoscopic cannulation in high risk patients[J].Endosc Int Open,2015,3(5):E464.
[9] JIN YJ,JEONG S,LEE DH.Utility of needle-knife fistulotomy as an initial method of biliary cannulation to prevent post-ERCP pancreatitis in a highly selected at-risk group:a single-arm prospective feasibility study[J].Gastrointest Endosc,2016,84(5):808.
[10] ZAGALSKY D,GUIDI MA,CURVALE C,et al.Early precut is as efficient as pancreatic stent in preventing post-ERCP pancreatitis in high-risk subjects-A randomized study[J].Rev Esp Enferm Dig,2016,108(9):258.
[11] 赵孝文,鲍峻峻,胡翠,等.经内镜鼻胆管引流对接受经内镜逆行胰胆管造影的胆总管结石病人并发术后胰腺炎的预防效果观察[J].临床肝胆病杂志,2014,30(8):746.
[12] YANG J,PENG JY,PANG EJ,et al.Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones:experience from a Chinese center[J].Dig Endosc,2013,25(4):453.
[13] 刘苗,邓涛,杨艳,等.鼻胆管引流预防内镜逆行胰胆管造影术后胰腺炎及高淀粉酶血症疗效的Meta分析[J].胃肠病学和肝病学杂志,2015,24(5):531.
[14] BENVENUTI S,ZANCANELLA L,PIAZZI L,et al.Prevention of post-ERCP pancreatitis with somatostatin versus gabexatemesylate:A randomized placebo controlled multicenter study[J].Dig Liver Dis,2006,38(Suppl 1):s15.
[15] 刘璐,邓涛,万新月,等.胰管支架预防高危ERCP术后胰腺炎的临床分析[J].胃肠病学和肝病学杂志,2013,22(11):1087.
[16] 李运红,姚玉玲,贺奇彬,等.胰管支架预防困难胆管插管ERCP术后急性胰腺炎的前瞻性研究[J].中华消化内镜杂志,2014,31(7):403.
[17] FAN JH,QIAN JB,WANG YM,et al.Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis[J].World J Gastroenterol,2015,21(24):7577.
[18] FREEMAN ML.Preventing post-ERCP pancreatitis:update 2016[J].Curr Treat Options Gastroenterol,2016,14(3):340.
[19] IQBAL S,SHAH S,DHAR V,et al.Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?[J].Dig Dis Sci,2011,56(1):260.
[20] ZHAO LN,YU T,LI CQ,et al.Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients[J].Exp Ther Med,2014,8(2):509.
[21] QIN X,LEI WS,XING ZX,et al.Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis:an updated meta-analysis[J].Saudi J Gastroenterol,2015,21(6):372.
[22] 张志斌.ERCP术后应用乌司他丁预防胰腺炎的疗效观察[J].天津医药,2013,41(8):831.
[23] 陈旭峰,向正国,李科军,等.不同时段静脉滴注乌司他丁预防ERCP术后胰腺炎效果分析[J].胃肠病学和肝病学杂志,2014,23(5):576.
[24] PARK JY,JEON TJ,HWANG MW,et al.Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications:a prospective,randomized trial[J].Pancreatology,2014,14(4):263.
[25] WANG J,SU J,LU Y,et al.A randomized control study to investigate the application of Ulinastatin-containing contrast medium to prevent post-ERCP pancreatitis[J].Hepatogastroenterology,2014,61(136):2391.
[26] 张俊,李非.加贝酯预防ERCP术后胰腺炎的Meta分析[J].中国普外基础与与临床杂志,2012,19(1):48.
[27] THIRUVENGADAM NR,FORDE KA,MA GK,et al.Rectal indomethacin reduces pancreatitis in high-and low-risk patients undergoing endoscopic retrograde cholangiopancreatography[J].Gastroenterology,2016,151(2):288.
[28] 郭虹,祁冉,郑玉峰,等.直肠应用吲哚美辛栓剂对ERCP术后病人高淀粉酶血症及胰腺炎的预防作用[J].中国生化药物杂志,2015,35(3):112.
[29] 丁全华,张优萍,李建阳.双氯芬酸钠栓剂预防ERCP术后胰腺炎及高淀粉酶血症的临床研究[J].浙江医学,2014,36(24):2015.
[30] 黄坤,于久飞.吲哚美辛预防ERCP术后胰腺炎的Meta分析[J].重庆医学,2014,43(32):4322.
[31] HAUSER G,BLAŽEVIĆ I,SALKIĆ N,et al.Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography:a prospective,randomized,controlled trial[J].Surg Endosc,2016,31(2):602.
[32] RUSTAGI T,NJEI B.Factors affecting the efficacy of nonsteroidal anti-inflammatory drugs in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis:a systematic review and Meta-analysis[J].Pancreas,2015,44(6):859.
[33] FREEMAN ML,GUDA NM.Prevention of post-ERCP pancreatitis:a comprehensive review[J].Gastrointest Endosc,2004,59(7):845.
[34] DIMAGNO MJ.Nitric oxide pathways and evidence-based perturbations in acute pancreatitis[J].Pancreatology,2007,7(5/6):403.
[35] 陈小微,洪万东,吴小丽,等.硝酸甘油预防经内镜逆行胰胆管造影术后胰腺炎及高淀粉酶血症的临床对照研究[J].中华消化内镜杂志,2012,29(4):181.
[36] 何小建,张志坚,李达周,等.生长抑素和硝酸甘油预防经内镜逆行胰胆管造影术后胰腺炎的疗效观察[J].中华消化内镜杂志,2014,31(4):206.
[37] 王广勇,施云星,吕礁,等.十二指肠乳头局部喷洒肾上腺素对胆总管结石ERCP术后胰腺炎的预防作用[J].中华胰腺病杂志,2015,15(6):406.
[38] AKSHINTALA VS,HUTFLESS SM,COLANTUONI E,et al.Systematic review with network meta-analysis:pharmacological prophylaxis against post-ERCP pancreatitis[J].Aliment Pharmacol Ther,2013,38(11/12):1325.
[39] 刘先秒,侯延平.高浓度硫酸镁预防经内镜逆行胰胆管造影术后胰腺炎和高淀粉酶血症的效果[J].右江医学,2014,42(6):672.
[40] 赵雩卿,刘晓红.大黄对急性胰腺炎多靶点的治疗作用[J].胃肠病学,2003,8(5):316.
[41] 王苏丽,周毅,姚茹,等.大黄保留灌肠预防逆行胰胆管造影术后胰腺炎和高淀粉酶血症的临床研究[J].中国中西医结合消化杂志,2012,20(12):545.
[42] 杨清峰,张旭,周磊.复方丹参联合奥曲肽治疗急性胰腺炎疗效观察[J].蚌埠医学院学报,2010,35(2):145.
[43] 陈海东,韦良宏,宁琳,等.静脉滴注丹参注射液预防ERCP术后高淀粉酶血症及急性胰腺炎的临床研究[J].内科,2014,9(4):392.
[44] CHOI JH,KIM HJ,LEE BU,et al.Vigorous periprocedural hydration with lactated ringer's solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients[J].Clin Gastroenterol Hepatol,2016,15(1):86.